首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1620360

微电子医疗植体市场：依产品、技术和地区划分，2024-2031

Microelectronic Medical Implants Market By Product (Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps), Technology (RF Technology, Sensors), & Region for 2024-2031

出版日期: 2024年07月21日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024-2031年微电子医疗植入物市场评估

对微电子医疗植入物的需求不断增加随着人口老化，心臟病、糖尿病和神经系统疾病等慢性疾病的盛行率不断增加。植入装置经常用于治疗多种疾病的症状并提高生活品质。 2024年市场规模将超过298.9亿美元，预计2031年将达到约502.1亿美元。

技术的进步使得能够开发出更小、更复杂的植入物，并具有改进的功能和可靠性。这使得这些设备更加通用并适合更多患者。人们越来越瞭解微创手术的好处以及更便宜的医疗保健解决方案的可用性正在推动对微电子医疗植入物的需求。对经济高效的微电子医疗植入物的需求不断增长，使得该市场从 2024 年到 2031 年的复合年增长率为 6.70%。

微电子医疗植入物市场定义/概述

微电子医疗植入物是将微电子技术融入医疗程序的先进设备。这些植入物被放置在人体中以监测、诊断和治疗许多医学疾病。例如心律调节器、人工耳蜗、神经刺激器和药物传输装置。透过使用微型组件，这些设备可以精确运作并实现长期健康监测和介入。这些设备应用于心臟病学、神经学和骨科等多个医疗领域，在治疗慢性疾病、提高患者的运动技能、恢復失去的感觉功能方面发挥着重要作用。

奈米技术、无线连接和生物相容性材料的进步预示着微电子医疗植入物的光明未来。脑机介面和智慧植入物等新发展有可能改变个人化医疗并改善癫痫、帕金森氏症和瘫痪等疾病的治疗结果。

慢性病的增加和人口老化将增加对这些植入物的需求，而小型化、电池寿命和数据整合的进步将其应用扩展到新的医疗领域。预计该技术将为患者提供更复杂且侵入性最小的护理选择，对医疗保健的未来产生重大影响。

心血管疾病日益普及将如何推动微电子医疗植入物市场？

心血管疾病盛行率的增加正在推动微电子医疗植入物市场的发展。心血管疾病仍然是世界上最主要的死亡原因，每年导致约 1790 万人死亡，这增加了对起搏器和植入式心律转復除颤器 (ICD) 等设备的需求。在美国，约有 270 万人患有心房颤动，通常需要使用心律调节器进行治疗。心臟相关疾病的日益流行强调了对这些挽救生命的植入物的需求，并推动了市场的扩张。

人口老化的加剧正在推动微电子医疗植入产业的发展。随着世界人口老化，65岁及以上的人口数量预计将从2019年的9%增加到2050年的16%，促使对治疗与年龄相关疾病的植入物的需求不断增加。在欧洲和美国，到 2050 年，四分之一的人将超过 65 岁，用于治疗慢性疾病和与年龄相关的健康状况的微电子植入物的需求预计将会增加。

手术风险将如何影响微电子医疗植入物市场的成长？

手术风险可能会阻碍微电子医疗植入物市场的成长。植入治疗具有感染、设备故障和身体排斥等潜在影响，可能会阻止患者和医疗保健提供者使用这些设备。手术的侵入性和相关的恢復时间引起了人们的担忧，并可能限制微电子植入物的使用。这些风险影响患者和提供者的选择并阻碍市场扩张。

高成本影响微电子医疗植入市场的扩张。这些设备（包括起搏器和神经刺激器）的製造、插入和持续维护通常成本高昂。对于患者来说，引入这项技术可能会很困难，因为它需要大量的初始成本，而且在某些国家保险范围有限。由于成本限制，新兴市场的医疗保健提供者可能难以提供这些先进的治疗方法，从而减缓市场扩张，特别是在低收入地区。

The growing demand for microelectronic medical implants. The aging population is rapidly increasing, resulting in a rising prevalence of chronic diseases like heart disease, diabetes, and neurological disorders. Implantable devices are frequently used to treat symptoms and improve the quality of life for several diseases. the market size surpass USD 29.89 Billion valued in 2024 to reach a valuation of aroundUSD 50.21 Billion by 2031.

Technological advancements have made it possible to create smaller, more sophisticated implants with increased functionality and reliability. This has broadened the spectrum of uses for these devices, making them more appropriate for a larger patient population. The increased knowledge of the benefits of minimally invasive procedures, as well as the availability of more inexpensive healthcare solutions, are driving up demand for microelectronic medical implants. The rising demand for cost-effective and efficient microelectronic medical implants is enabling the market grow at aCAGR of 6.70% from 2024 to 2031.

Microelectronic Medical Implants Market: Definition/ Overview

Microelectronic medical implants are advanced devices that incorporate microelectronics technology into medical procedures. These implants are placed in the human body to monitor, diagnose, and treat a number of medical diseases. Pacemakers, cochlear implants, neurostimulators, and drug-delivery devices are some examples. Using micro-scale components, these devices work with accuracy, allowing for long-term health monitoring and intervention. They are used in a variety of medical sectors, including cardiology, neurology, and orthopedics, where they serve an important role in treating chronic diseases, increasing patient mobility, and recovering lost sensory functions.

Advances in nanotechnology, wireless connectivity, and biocompatible materials point to a bright future for microelectronic medical implants. Emerging developments, such as brain-computer interfaces and smart implants, have the potential to transform personalized medicine and improve treatment outcomes for disorders like epilepsy, Parkinson's disease, and paralysis.

The rising frequency of chronic diseases and an aging population will drive demand for these implants, while advances in reduction, battery life, and data integration will expand their applicability to new medical sectors. This technology is projected to have a big impact on the future of healthcare by providing more complex, minimally intrusive patient care options.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How will the Increasing Prevalence of Cardiovascular Diseases Drive the Microelectronic Medical Implants Market?

The increasing prevalence of cardiovascular diseases is propelling the microelectronic medical implants market. As cardiovascular diseases continue to be the largest cause of mortality in the world, killing around 17.9 million people each year, the need for devices such as pacemakers and implantable cardioverter-defibrillators (ICDs) grows. With about 2.7 million people in the United States suffering from atrial fibrillation, which is frequently treated with pacemakers, the rising prevalence of heart-related illnesses emphasizes the need for these life-saving implants, driving market expansion.

The growing geriatric population is boosting the microelectronic medical implant industry. As the world's population ages, with the number of persons aged 65 and older expected to climb from 9% in 2019 to 16% by 2050, there is an increasing demand for implants to treat age-related illnesses. In Europe and North America, where one in every four individuals will be beyond the age of 65 by 2050, demand for microelectronic implants to treat chronic diseases and age-related health conditions is predicted to rise.

How Does the Surgical Risks Affect the Growth of the Microelectronic Medical Implants Market?

Surgical risks can impede the growth of the microelectronic medical implants market. Implant treatments have potential consequences such as infections, device malfunction, and body rejection, which may prevent patients and healthcare providers from using these devices. The invasive nature of the surgeries and the associated recovery time may create concerns, restricting the use of microelectronic implants. These risks hinder market expansion by influencing patient and provider choices.

High costs will affect the expansion of the microelectronic medical implants market. These devices, which include pacemakers and neurostimulators, frequently cost significant costs for manufacturing, insertion, and continuing maintenance. Patients may struggle to adopt due to significant upfront fees and limited insurance coverage in certain countries. Healthcare providers in developing markets may struggle to provide these advanced therapies due to cost constraints, thereby slowing market expansion, particularly in lower-income regions.

Category-Wise Acumens

Will the Increasing Prevalence of Cardiovascular Diseases Fuel the Pacemakers & Defibrillators Segment for the Microelectronic Medical Implants Market?

Pacemakers and defibrillators have long held a leading position in the microelectronic medical implant market. The rising prevalence of cardiovascular disorders will propel the pacemakers and defibrillators segment of the microelectronic medical implants market. As arrhythmias and heart failure become increasingly widespread, so does the demand for life-saving technologies like pacemakers and implantable defibrillators. With cardiovascular disease being the leading cause of death globally, accounting for 17.9 million deaths per year according to the WHO, and conditions such as atrial fibrillation affecting millions, these devices are essential for managing and treating heart disorders, fueling the growth of this segment.

The increasing use of pacemakers and defibrillators to treat heart arrhythmias, particularly among the elderly, will fuel the expansion of this area of the microelectronic medical implants market. As the world's population ages, the prevalence of arrhythmias and other heart disorders rises, necessitating the usage of these devices for effective therapy. With an increasing older population prone to cardiovascular problems, demand for pacemakers and defibrillators is predicted to explode, propelling market expansion in this sector.

Does Remote Monitoring and Programming Boost the RF Technology Segment in the Microelectronic Medical Implants market?

RF Technology is emerging as the fastest-expanding segment in the microelectronic medical implant market. Remote monitoring and programming will propel the RF technology segment of the microelectronic medical implants market. As medical implants incorporate more wireless capabilities for remote monitoring and programming, the demand for improved RF technology rises. This technology enables real-time data transfer and device adjustments without the need for intrusive procedures, which improves patient care and convenience. Adopting RF technology is consequently essential to enhancing the functioning and efficiency of medical implants, thereby driving their market growth.

Reducing the demand for frequent surgical interventions will propel the RF technology segment of the microelectronic medical implants market. RF technology allows wireless communication for remote monitoring and programming of medical implants, reducing the need for invasive procedures and frequent surgeries. By allowing healthcare providers to make adjustments and monitor device performance remotely, RF technology improves patient comfort while reducing healthcare costs, increasing acceptance, and driving growth in this segment.

Country/Region-wise Acumens

Will the Strong Healthcare Infrastructure Lead the North American Region for the Microelectronic Medical Implants Market?

North America is the leading region in the microelectronic medical implant market. North America's microelectronic medical implant market will be driven by its robust healthcare infrastructure. The region's significant investment in healthcare, with US national health expenditure hitting USD 4.3 Trillion in 2021 and projected to reach USD 6.8 Trillion by 2031, encourages the use of modern medical technologies. Over 6,000 institutions in the United States are equipped with advanced procedures, and Canada's USD 308 Billion health expenditure in 2021 demonstrates its commitment to funding such breakthroughs. This solid base fuels the demand for sophisticated implants in the region.

Advanced research and development (R&D) will propel the microelectronic medical implants market in North America. The region's significant R&D investments, with US expenditures hitting USD 667 Billion in 2020 and expected to exceed USD 700 Billion by 2023, demonstrate a strong concentration on medical technology advancement. The FDA approved 132 innovative medical devices in 2021, a 39% increase over 2017, demonstrating significant innovation. The predicted growth of the global neurostimulation devices market from USD 7.6 Billion in 2022 to USD 13.3 Billion in 2027 demonstrates the significance of these breakthroughs. Furthermore, major R&D spending by the US semiconductor sector contributes to the development of advanced microelectronic implants.

Will the Manufacturing Hubs in the Asia Pacific Region Drive the Microelectronic Medical Implants Market?

Asia-Pacific is emerging as the fastest-growing region in the microelectronic medical implants market. Manufacturing hubs will fuel Asia-Pacific's microelectronic medical implant market. The region's supremacy in semiconductor manufacture, with the Asia-Pacific industry estimated to reach USD 395 Billion by 2022 and expand at a 10% CAGR, is critical for cost-effective implant production. China's medical device market, worth USD 137 Billion in 2021, and India's expected expansion to USD 50 Billion by 2025, aided by large government incentives, strengthen the region's manufacturing capabilities. These features, together with expanding healthcare requirements and chronic illness incidence, place the Asia-Pacific region at the leading edge of making microelectronic implants more accessible and inexpensive.

The Asia-Pacific region's huge and expanding population is driving the market for microelectronic medical implants. The region's 4.3 billion population is rapidly aging, with the number of individuals aged 60 and up anticipated to almost triple to 1.3 billion by 2050. This generational transition, combined with the high incidence of noncommunicable disorders including cardiovascular disease and diabetes, is driving strong demand for advanced medical implants. The market for implantable medical devices in the region is expected to rise from USD 23.1 Billion in 2023 to USD 32.1 Billion by 2028, indicating rising healthcare needs and the prevalence of chronic diseases.

Competitive Landscape

The microelectronic medical implants market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the microelectronic medical implants market include:

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Zimmer Biomet
Cochlear Limited
LivaNova PLC
Second Sight Medical Products, Inc.
Nurotron Biotechnology Co. Ltd.
Biotronik SE & Co. KG
Nevro Corp
Sonova Holding AG.

Latest Developments

In February 2021, Medtronic gained FDA approval for their next-generation Micra pacemaker, the world's tiniest pacemaker. The device is intended to be implanted directly into the heart, providing a minimally invasive alternative to standard pacemakers.
In August 2021, Abbott Laboratories announced that the FDA has approved their Infinity DBS system, which is a deep brain stimulation device used to treat Parkinson's disease and essential tremors. The gadget incorporates modern stimulation technology that enables individualized therapy and real-time patient feedback.
In September 2021, LivaNova announced the debut of its next-generation Vagus Nerve Stimulation (VNS) therapeutic device for epilepsy. The system uses advanced simulation technology to provide patients with a tailored approach to therapy.

1 INTRODUCTION OF GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET

1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET OUTLOOK

4.1 OVERVIEW
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.2 RESTRAINTS
- 4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET, BY TECHNOLOGIES

5.1 OVERVIEW
5.2 RF TECHNOLOGIES
5.3 SENSORS
5.4 OTHERS

6 GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 PACEMAKERS AND DEFIBRILLATORS
6.3 NEUROSTIMULATOR
6.4 IMPLANTABLE DRUG PUMPS
6.5 COCHLEAR IMPLANTS
6.6 OCULAR IMPLANTS
6.7 RETINAL IMPLANTS
6.8 OTHERS

7 GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET, BY GEOGRAPHY

7.1 OVERVIEW
7.2 NORTH AMERICA
- 7.2.1 U.S.
- 7.2.2 CANADA
- 7.2.3 MEXICO
7.3 EUROPE
- 7.3.1 GERMANY
- 7.3.2 U.K.
- 7.3.3 FRANCE
- 7.3.4 REST OF EUROPE
7.4 ASIA PACIFIC
- 7.4.1 CHINA
- 7.4.2 JAPAN
- 7.4.3 INDIA
- 7.4.4 REST OF ASIA PACIFIC
7.5 REST OF THE WORLD
- 7.5.1 LATIN AMERICA
- 7.5.2 MIDDLE EAST AND AFRICA

8 GLOBAL MICROELECTRONIC MEDICAL IMPLANTS MARKET COMPETITIVE LANDSCAPE

8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES

9 COMPANY PROFILES

9.1 ABBOTT LABORATORIES
- 9.1.1 OVERVIEW
- 9.1.2 FINANCIAL PERFORMANCE
- 9.1.3 PRODUCT OUTLOOK
- 9.1.4 KEY DEVELOPMENTS
9.2 MEDTRONIC PLC
- 9.2.1 OVERVIEW
- 9.2.2 FINANCIAL PERFORMANCE
- 9.2.3 PRODUCT OUTLOOK
- 9.2.4 KEY DEVELOPMENTS
9.3 BOSTON SCIENTIFIC CORPORATION
- 9.3.1 OVERVIEW
- 9.3.2 FINANCIAL PERFORMANCE
- 9.3.3 PRODUCT OUTLOOK
- 9.3.4 KEY DEVELOPMENTS
9.4 ZIMMER BIOMET
- 9.4.1 OVERVIEW
- 9.4.2 FINANCIAL PERFORMANCE
- 9.4.3 PRODUCT OUTLOOK
- 9.4.4 KEY DEVELOPMENTS
9.5 COCHLEAR LIMITED
- 9.5.1 OVERVIEW
- 9.5.2 FINANCIAL PERFORMANCE
- 9.5.3 PRODUCT OUTLOOK
- 9.5.4 KEY DEVELOPMENTS
9.6 LIVANOVA PLC
- 9.6.1 OVERVIEW
- 9.6.2 FINANCIAL PERFORMANCE
- 9.6.3 PRODUCT OUTLOOK
- 9.6.4 KEY DEVELOPMENTS
9.7 SECOND SIGHT MEDICAL PRODUCTS, INC.
- 9.7.1 OVERVIEW
- 9.7.2 FINANCIAL PERFORMANCE
- 9.7.3 PRODUCT OUTLOOK
- 9.7.4 KEY DEVELOPMENTS
9.8 NUROTRON BIOTECHNOLOGY CO. LTD.
- 9.8.1 OVERVIEW
- 9.8.2 FINANCIAL PERFORMANCE
- 9.8.3 PRODUCT OUTLOOK
- 9.8.4 KEY DEVELOPMENTS
9.9 BIOTRONIK SE & CO. KG
- 9.9.1 OVERVIEW
- 9.9.2 FINANCIAL PERFORMANCE
- 9.9.3 PRODUCT OUTLOOK
- 9.9.4 KEY DEVELOPMENTS
9.10 NEVRO CORP
- 9.10.1 OVERVIEW
- 9.10.2 FINANCIAL PERFORMANCE
- 9.10.3 PRODUCT OUTLOOK
- 9.10.4 KEY DEVELOPMENTS